drugset / Trial / NCT01812889

Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463

NCT01812889 ↗

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine the safety, local tolerability and pharmacokinetic parameters of TOL-463 intravaginal dosage forms in both healthy, nonpregnant females following single dose administration (Part 1), and in nonpregnant women with vaginitis following multi-dose administration (Part 2).

Timeline

Start
2013-04
Primary completion
2014-01
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator TOL-463 Other / unclassified — Other

Indications